Factors associated with professional support access among a prospective cohort of methamphetamine users

Journal of Substance Abuse Treatment

Volumn 45, Issue 2, 2013, Pages 235-241

  Quinn, Brendan ^a,b   Stoové, Mark ^a,b   Dietze, Paul ^a,b  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Amphetamine; Australia; Community based research; Epidemiology; Melbourne; Methamphetamine; Polysubstance use; Prospective cohort study; Social support; Treatment access; Treatment utilisation

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; AUSTRALIA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHAMPHETAMINE DEPENDENCE; PRIORITY JOURNAL;

ADULT; AMPHETAMINE-RELATED DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTITIONERS; HEALTH SERVICES ACCESSIBILITY; HUMANS; LOGISTIC MODELS; MALE; METHAMPHETAMINE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; VICTORIA;

EID: 84879141677     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2013.02.003     Document Type: Article

References (53)

1. Baker A., Boggs T.G., Lewin T.J. Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review 2001, 20:49-56.
2. Baker A., Dawe S. Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist 2005, 40(2):88-95.
3. Baker A., Lee N.K. A review of psychosocial interventions for amphetamine use. Drug and Alcohol Review 2003, 22:323-335.
4. Baker A., Lee N.K., Claire M., Lewin T.J., Grant T., Pohlman S., Saunders J.B., Kay-Lambkin F., Constable P., Jenner L., Carr V.J. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction 2005, 100(3):367-378.
5. Borders T.F., Booth B.M., Han X., Wright P., Leukefeld C., Falck R.S., Carlson R.G. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: Racial differences and the impact of methamphetamine legislation. Addiction 2008, 103(5):800-808.
6. Boshears P., Boeri M., Harbry L. Addiction and sociality: Perspectives from methamphetamine users in suburban USA. Addict Research Theory 2011, 19(4):289-301.
7. Brecht M., Greenwell L., Anglin M.D. Methamphetamine treatment: Trends and predictors of retention and completion in a large state treatment system (1992-2002). Journal of Substance Abuse Treatment 2005, 29:295-306.
8. Christian D.R., Huber A., Brecht M.L., McCann M.J., Marinelli-Casey P., Lord R.H., Reiber C., Lu T.H., Project T.M.T., Galloway G.P. Methamphetamine users entering treatment: Characteristics of the methamphetamine treatment project sample. Substance Use & Misuse 2007, 42(14):2207-2222.
9. Cogger S., McKetin R., Ross J., Najman J. Methamphetamine Treatment Evaluation Study (MATES): Findings from the Brisbane Site Technical Report No. 295 2008, National Drug and Alcohol Research Centre, Sydney.
10. Cui J. QIC program and model selection in GEE analyses. The Stata Journal 2007, 7(2):209-220.
11. Cunningham J.A. Untreated remissions from drug use: The predominant pathway. Addictive Behaviors 1999, 24(2):267-270.
12. Darke S., Hall W. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug and Alcohol Dependence 1995, 39(3):231-235.
13. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction 1992, 87:733-742.
14. Darke S., Kaye S., McKetin R., Duflou J. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 2008, 27(3):253-262.
15. Darke S., Ross J., Teesson M., Lynskey M. Health service utilization and benzodiazepine use among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2003, 98(8):1129-1135.
16. Degenhardt L., Mathers B., Guarinieri M., Panda S., Phillips B., Strathdee S.A., Tyndall M., Wiessing L., Wodak A., Howard J. Meth/amphetamine use and associated HIV: Implications for global policy and public health. The International Journal on Drug Policy 2010, 21:347-358. Reference Group to the United Nations on HIV and injecting drug use.
17. Dolan K., MacDonald M., Silins E., Topp L. Needle and syringe programs: A review of the evidence 2005, Australian Government Department of Health and Ageing, Canberra.
18. Gonzales R., Ang A., Marinelli-Casey P., Glik D.C., Iguchi M.Y., Rawson R.A. Health-related quality of life trajectories of methamphetamine-dependent individuals as a function of treatment completion and continued care over a 1-year period. Journal of Substance Abuse Treatment 2009, 37(4):353-361.
19. Gossop M., Marsden J., Stewart D. Treatment outcomes of stimulant misusers: one year follow-up results from the National Treatment Outcome Research Study (NTORS). Addictive Behaviors 2000, 25(4):509-522.
20. Gottlieb B.H., Bergen A.E. Social support concepts and measures. Journal of Psychosomatic Research 2010, 69(5):511-520.
21. Gray S.D., Fatovich D.M., McCoubrie D.L., Daly F.F. Amphetamine-related presentations to an inner-city tertiary emergency department: A prospective evaluation. The Medical Journal of Australia 2007, 186(7):336-339.
22. Hando J., Topp L., Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence 1997, 46:105-113.
23. Hendrickson R.G., Cloutier R., McConnell K.J. Methamphetamine-related emergency department utilization and cost. Academic Emergency Medicine 2008, 15(1):23-31.
24. Hindler C., Nazareth I., King M., Cohen J., Farmer R., Gerada C. Drug users' views on general practitioners. BMJ 1995, 310(6975):302.
25. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, Wiley, New York. 2nd ed.
26. Hser Y.I., Huang D., Brecht M.L., Li L., Evans E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. Journal of Addictive Diseases 2008, 27(3):13-21.
27. Huber A., Ling W., Shoptaw S., Gulati V., Brethen P., Rawson R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases 1997, 16(4):41-50.
28. Joe G.W., Simpson D.D., Broome K.M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998, 93(8):1177-1190.
29. Kay-Lambkin F.J., Baker A.L., McKetin R., Lee N. Stepping through treatment: Reflections on an adaptive treatment strategy among methamphetamine users with depression. Drug and Alcohol Review 2010, 29:475-482.
30. Kelly E., McKetin R., McLaren J. Health service utilisation among regular methamphetamine users (vol. technical report no. 233) 2005, National Drug and Alcohol Research Centre, Sydney.
31. Kessler R.C. Kessler Psychological Distress Scale (K10) 1996, Harvard Medical School, Boston, MA.
32. Klee H., Morris J. Factors that lead young amphetamine misusers to seek help: Implications for drug prevention and harm reduction. Drugs: Education, Prevention and Policy 1994, 1(3):289-297.
33. Leonard L., DeRubeis E., Pelude L., Medd E., Birkett N., Seto J. "I inject less as I have easier access to pipes": Injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed. The International Journal on Drug Policy 2008, 19(3):255-264.
34. Lloyd B. Trends in alcohol and drug related ambulance attendances in Melbourne: 2010/11 2012, Turning Point Alcohol and Drug Centre, Fitzroy, Victoria.
35. McGeary K.A., French M.T. Illicit drug use and emergency room utilization. HSR: Health Services Research 2000, 35(1):153-169.
36. McKetin R., Kelly E. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia. Drug and Alcohol Review 2007, 26:161-168.
37. McKetin R., Kelly E., Indig D. Characteristics of treatment provided for amphetamine use in New South Wales, Australia. Drug and Alcohol Review 2005, 24(5):433-436.
38. McKetin R., Kelly E., McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug and Alcohol Dependence 2006, 85(3):198-204.
39. McKetin R., Lubman D.I., Lee N.M., Ross J.E., Slade T.N. Major depression among methamphetamine users entering drug treatment programs. The Medical Journal of Australia 2011, 195(3):S51-S55.
40. McKetin R., Ross J., Kelly E., Baker A., Lee N., Lubman D.I., Mattick R. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug and Alcohol Review 2008, 27(3):277-285.
41. Mitchell P.H., Powell L., Blumenthal J., Norten J., Ironson G., Pitula C.R., Froelicher E.S., Czajkowski S., Youngblood M., Huber M., Berkman L.F. A short social support measure for patients recovering from myocardial infarction: The ENRICHD Social Support Inventory. Journal of Cardiopulmonary Rehabilitation 2003, 23(6):398-403.
42. Nielsen S., Bruno R., Lintzeris N., Fischer J., Carruthers S., Stoové M. Pharmaceutical opioid analgesic and heroin dependence: How do treatment-seeking clients differ in Australia?. Drug and Alcohol Review 2011, 30(3):291-299.
43. Pennay A., Ferris J., Reed M., Devaney M., Lee N. Evaluation of 'access point' specialist methamphetamine clinic 2010, Turning Point Alcohol and Drug Centre, Fitzroy, Melbourne.
44. Quinn, B., Stoové, M., & Dietze, P. (Submitted). One-year changes in methamphetamine use, dependence and remission in a community-recruited cohort. Drug Alcohol Depend.
45. Quinn B., Stoové M., Papanastasiou C., Dietze P. Methamphetamine use in Melbourne, Australia: Baseline characteristics of a prospective methamphetamine-using cohort and correlates of methamphetamine dependence. Journal of Substance Use 2012, 1-14.
46. Quinn, B., Stoové, M., Papanastasiou, C., & Dietze, P. (Submitted). An exploration of self-perceived non-problematic use and other barriers to professional support for methamphetamine users. Int J Drug Policy.
47. Saltman D.C., Newman C.E., Mao L., Kippax S.C., Kidd M.R. Experiences in managing problematic crystal methamphetamine use and associated depression in gay men and HIV positive men: In-depth interviews with general practitioners in Sydney, Australia. BMC Family Practice 2008, 9(45):1-7.
48. Semple S.J., Grant I., Patterson T.L. Utilization of drug treatment programs by methamphetamine users: The role of social stigma. The American Journal on Addictions 2005, 14(4):367-380.
49. Strathdee S.A., Ricketts E.P., Huettner S., Cornelius L., Bishai D., Havens J.R., Beilenson P., Rapp C., Lloyd J.J., Latkin C.A. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug and Alcohol Dependence 2006, 83(3):225-232.
50. Szklo M. Population-based cohort studies. Epidemiologic Reviews 1998, 20(1):81-90.
51. Topp L., Mattick R.P. Choosing a cutoff on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997, 92(7):839-845.
52. Vincent N., Shoobridge J., Ask A., Allsop S., Ali R. Characteristics of amphetamine users seeking information, help and treatment in Adelaide, South Australia. Drug and Alcohol Review 1999, 18:63-73.
53. Wallace C., Galloway T., McKetin R., Kelly E., Leary J. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia. Drug and Alcohol Review 2009, 28:592-599.